tradingkey.logo

OrthoPediatrics Corp reports results for the quarter ended June 30 - Earnings Summary

ReutersAug 5, 2025 9:41 PM
  • OrthoPediatrics Corp KIDS.OQ reported a quarterly adjusted loss of 30 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -26 cents. The mean expectation of seven analysts for the quarter was for a loss of 30 cents per share. Wall Street expected results to range from -38 cents to -24 cents per share.

  • Revenue rose 15.7% to $61.08 million from a year ago; analysts expected $61.40 million.

  • OrthoPediatrics Corp's reported EPS for the quarter was a loss of 30 cents​.

  • The company reported a quarterly loss of $7.11 million.

  • OrthoPediatrics Corp shares had fallen by 4.4% this quarter and lost 11.4% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had risen by about 1.3% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

  • Wall Street's median 12-month price target for OrthoPediatrics Corp is $37.00, about 44.5% above its last closing price of $20.53

This summary was machine generated from LSEG data August 5 at 09:40 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2025

-0.30

-0.30

Met

Mar. 31 2025

-0.45

-0.46

Missed

Dec. 31 2024

-0.31

-0.69

Missed

Sep. 30 2024

-0.24

-0.34

Missed

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
KeyAI